citalopram has been researched along with Cerebrovascular Disorders in 8 studies
Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.
Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of the study was to investigate the efficacy and safety of the selective serotonin reuptake inhibitor citalopram in treating poststroke depression, since available treatments are usually poorly tolerated." | 9.07 | Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. ( Andersen, G; Lauritzen, L; Vestergaard, K, 1994) |
| " Adverse events (AEs) were assessed with the Treatment Emergent Symptom Scale (TESS)." | 6.90 | A controlled study of the efficacy and safety of tandospirone citrate combined with escitalopram in the treatment of vascular depression: A pilot randomized controlled trial at a single-center in China. ( Chen, H; Chen, R; Lin, F; Lin, Q; Lin, T; Lin, X; Lin, Y; Luo, L; Xiao, Y, 2019) |
| "The aim of the study was to investigate the efficacy and safety of the selective serotonin reuptake inhibitor citalopram in treating poststroke depression, since available treatments are usually poorly tolerated." | 5.07 | Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. ( Andersen, G; Lauritzen, L; Vestergaard, K, 1994) |
| " Adverse events (AEs) were assessed with the Treatment Emergent Symptom Scale (TESS)." | 2.90 | A controlled study of the efficacy and safety of tandospirone citrate combined with escitalopram in the treatment of vascular depression: A pilot randomized controlled trial at a single-center in China. ( Chen, H; Chen, R; Lin, F; Lin, Q; Lin, T; Lin, X; Lin, Y; Luo, L; Xiao, Y, 2019) |
| "Citalopram was well tolerated, the few side-effects being mild and transient." | 2.67 | Citalopram for post-stroke pathological crying. ( Andersen, G; Riis, JO; Vestergaard, K, 1993) |
| "A 28-year-old woman had thunderclap headache (TCH), after 7 days she had left hemiparesis." | 1.35 | Reversible cerebral vasoconstriction syndrome: case report. ( Bek, S; Demirkaya, S; Eroğlu, E; Odabaşi, Z; Oz, O; Ulaş, UH, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H | 1 |
| Lin, Q | 1 |
| Lin, T | 1 |
| Lin, Y | 1 |
| Lin, X | 1 |
| Chen, R | 1 |
| Luo, L | 1 |
| Lin, F | 1 |
| Xiao, Y | 1 |
| Oz, O | 1 |
| Demirkaya, S | 1 |
| Bek, S | 1 |
| Eroğlu, E | 1 |
| Ulaş, UH | 1 |
| Odabaşi, Z | 1 |
| Robinson, RG | 1 |
| Tenev, V | 1 |
| Jorge, RE | 1 |
| Andersen, G | 4 |
| Vestergaard, K | 3 |
| Lauritzen, LU | 1 |
| van Gijn, J | 1 |
| Riis, JO | 1 |
| Lauritzen, L | 1 |
1 review available for citalopram and Cerebrovascular Disorders
| Article | Year |
|---|---|
Treatment of uncontrolled crying after stroke.
Topics: Cerebrovascular Disorders; Citalopram; Crying; Depression; Humans; Male; Middle Aged | 1995 |
5 trials available for citalopram and Cerebrovascular Disorders
| Article | Year |
|---|---|
A controlled study of the efficacy and safety of tandospirone citrate combined with escitalopram in the treatment of vascular depression: A pilot randomized controlled trial at a single-center in China.
Topics: Aged; Antidepressive Agents; Cerebrovascular Disorders; China; Citalopram; Depression; Drug Therapy, | 2019 |
Citalopram for continuation therapy after repetitive transcranial magnetic stimulation in vascular depression.
Topics: Activities of Daily Living; Aged; Antidepressive Agents; Cerebrovascular Disorders; Citalopram; Depr | 2009 |
[Effective treatment of depression following apoplexy with citalopram].
Topics: Cerebrovascular Disorders; Citalopram; Depressive Disorder; Double-Blind Method; Humans; Prognosis | 1995 |
Citalopram for post-stroke pathological crying.
Topics: Adult; Affective Symptoms; Aged; Aged, 80 and over; Cerebrovascular Disorders; Citalopram; Crying; D | 1993 |
Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram.
Topics: Adult; Aged; Aged, 80 and over; Cerebrovascular Disorders; Citalopram; Cohort Studies; Depression; D | 1994 |
2 other studies available for citalopram and Cerebrovascular Disorders
| Article | Year |
|---|---|
Reversible cerebral vasoconstriction syndrome: case report.
Topics: Adult; Angiography, Digital Subtraction; Anti-Inflammatory Agents, Non-Steroidal; Brain Infarction; | 2009 |
Treating uncontrolled crying after stroke.
Topics: Cerebrovascular Disorders; Citalopram; Crying; Humans | 1993 |